Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record.

Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators

Lovejoy, D., Richardson, D. · 2003 · Current Medicinal Chemistry

Abstract

The chelator currently used to treat iron (Fe) overload disease, desferrioxamine (DFO), has shown anti-proliferative activity against leukemia and neuroblastoma cells in vitro, in vivo and in clinical trials. Collectively, these studies suggest that Fe-deprivation may be a useful anti-cancer strategy. However, the efficacy of DFO is severely limited due to its poor ability to permeate cell membranes and bind intracellular Fe pools. These limitations have encouraged the development of other Fe chelators that are far more effective than DFO. One group of ligands that have been extensively investigated are those of the pyridoxal isonicotinoyl hydrazone (PIH) class. In this review the marked anti-proliferative effects of the PIH analogs are discussed with reference to their mechanisms of action and structure-activity relationships. In particular, we discuss the activity of a novel group of ligands that are "hybrid" chelators derived from our most effective PIH analogs and thiosemicarbazones. The anti-tumor activity of the PIH analogs and other chelators such as tachpyridine, O-trensox and the desferrithiocin analogs have been well characterized in vitro. However, further studies in animals are critical to evaluate their selective anti-tumor activity and potential as therapeutic agents.

Overview

Integrity signals

Registry

Crossref · 10.2174/0929867033457557

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 100

Metadata

Authors
Lovejoy, D., & Richardson, D.
Affiliations
Children's Cancer Institute Australia (AU)
Venue
Current Medicinal Chemistry
Published
2003-06-01
Volume
10
Issue
12
Pages
1035-1049
ISSN
0929-8673 (ISSN-L)
OpenAlex
W2002176182
Cited by
98
References
0
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 6 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 1 · 2017: 1 · 2016: 4 · 2015: 4 · 2014: 5 · 2013: 5 · 2012: 4
FWCI
3.96
Type
journal article
Language
en
Open access
closed
Locations
  • Current Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
  • Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
Keywords
iron chelators, pyridoxal isonicotinoyl hydrazone, deferoxamine, iron starvation, anticancer agents, antiproliferative activity, leukemia, neuroblastoma, thiosemicarbazones, structure-activity relationship, iron overload
MeSH terms
Animals, Antineoplastic Agents, Deferoxamine, Humans, Hydrazones, Iron, Iron Chelating Agents, Neoplasms, Structure-Activity Relationship

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators. https://app.cochat.ai/papers/10.2174/0929867033457557
The paper
Lovejoy, D., & Richardson, D. (2003). Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators. Current Medicinal Chemistry. https://doi.org/10.2174/0929867033457557

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.